Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Cannae Holdings, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
1,191
1,170
1,321
1,443
2,965
742
662
570
453
424
Cost of revenue
984
991
991
571
475
371
358
Gross profit
207
179
329
90.7
95.1
81.3
65.6
Operating expenses
1,181
1,248
1,355
Operating income
-2.2
-77.5
-146
-118
-189
-134
-145
-119
-104
-120
Interest expense
5.2
7
4.7
17.8
9
9.8
12.3
17.9
11.6
11.9
Interest income
3.3
5.3
6.3
15.6
17.2
21.1
2.5
13.6
4.6
10.1
Other non-operating income
7.4
3.2
168
356
2,370
-300
-191
-81.5
-148
-70.9
Pre-tax income
5.2
-74.3
22.6
238
2,182
-433
-336
-200
-252
-191
Income tax
-10.4
-14.2
15
24.2
481
-74
-89.9
-71.5
3.3
13
Income from continuing operations
-14.3
-40.4
29.5
128
1,786
-287
Net income to minority interests
0.5
-16.3
-38.2
-30.5
-26.4
0.6
-1.5
-10.7
-5.5
-11.7
Net income
-12.4
109
27.6
77.3
1,786
-287
-428
-313
-305
-513
EBITDA
60.7
-19.4
-84.5
-63.1
-158
-107
-122
-99.9
-90.4
-108
EPS, basic
-0.18
1.54
0.39
1.07
20.84
-3.19
-5.25
-4.27
-4.73
-9.08
EPS, diluted
-0.18
1.54
0.39
1.07
20.79
-3.19
-5.25
-4.27
-4.73
-9.08
Shares, basic (weighted)
70.6
70.6
71.2
72.2
85.7
90.1
81.6
73.4
64.4
56.5
Shares, diluted (weighted)
70.6
70.6
71.3
72.4
85.9
90.1
81.6
73.4
64.4
56.5
Balance sheet
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
146
246
316
534
725
85.8
248
106
132
182
Short-term investments
0
31.4
0.5
35.2
0
Receivables
24.7
35.8
30.4
16
Inventory
23.9
29.7
22.3
16.3
Other current assets
8.7
21.4
22.1
97.2
84.3
35.8
26.1
29.5
23.5
25.7
Total current assets
273
350
452
631
844
122
311
177
197
257
Property, plant and equipment
235
219
176
163
146
101
87.5
58.7
61.8
49
Lease right-of-use assets
0
193
202
172
156
144
136
117
Goodwill
103
103
76.5
66.1
53.4
53.4
53.4
53.4
53.4
53.4
Intangible assets
112
215
92.4
63.1
51.8
26.9
23.5
16.8
15.1
13.2
Long-term investments
25
14.8
17.8
19.2
0
Total assets
1,473
1,487
1,460
2,092
4,613
3,890
3,126
2,687
2,229
1,309
Accounts payable
24.7
20.3
23
19.6
25.7
22.7
25.8
27
16.6
16.8
Accrued liabilities
20.4
23.7
22.8
25.3
21.5
24.4
13.3
12.8
15.5
9.4
Deferred revenue
24.7
26.1
25.8
26.4
23.9
23.1
18.6
16.9
16.2
16.1
Short-term debt
11.4
122
5.9
7
11.3
2.3
2.3
2.5
61
6.3
Total current liabilities
160
250
160
199
202
180
123
108
147
130
Long-term debt
93.3
12.7
42.2
120
52.2
14.1
95.1
103
120
64.5
Lease liabilities
0
200
196
166
151
142
135
123
Other non-current liabilities
29.4
29.5
Total liabilities
464
334
260
562
828
549
411
378
414
330
Total debt
105
135
48.1
127
63.5
16.4
97.4
105
181
70.8
Paid-in capital
0
1,130
1,146
1,397
1,876
1,888
1,936
1,977
2,013
2,041
Retained earnings
0
0.2
45.8
144
1,930
1,643
1,215
901
567
11.5
Treasury stock
0
-0.2
-5.9
-21.1
-189
-414
-534
-725
-1,047
Other comprehensive income
-68.1
-71
-67.2
-45.9
-4.9
-7.2
-18.1
-19.9
-19.2
6.5
Shareholders' equity
894
1,059
1,125
1,489
3,780
3,335
2,719
2,325
1,837
1,012
Minority interests
116
93.7
75.1
41.3
5.6
5.8
-3.9
-15.3
-21.2
-32.9
Total equity
1,010
1,153
1,200
1,530
3,785
3,341
2,715
2,309
1,815
979
Total liabilities and equity
1,473
1,487
1,460
2,092
4,613
3,890
3,126
2,687
2,229
1,309
Shares outstanding
70.9
72.2
79.5
91.7
86.9
76.3
70.4
62.8
46.7
Cash flow statement
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-11.9
92.5
-10.6
46.8
1,760
-286
-430
-324
-310
-525
Depreciation and amortization
62.9
58.1
61.3
54.5
30.7
26.4
22.8
19
13.3
11.9
Stock-based compensation
1.2
0.5
21.8
4.6
4.2
2.4
1.5
3.5
19
18.7
Deferred income tax
-16.6
14.2
-12.3
-40.5
365
-176
-156
-53.3
11.6
66.4
Change in receivables
-4.2
-1.2
-7.3
18.2
-1.6
Cash from operations
60.3
-90.7
-22.9
-84.2
-114
-176
-205
-87.8
-90.1
-18.1
Capital expenditures
-49.6
-39
-15.6
-28.3
-22.3
-13.7
-14.3
-10
-7
-10.4
Acquisitions
-75.8
-223
0
0
Purchases of investments
0
-1.3
-3.5
0
-0.7
0
-34.9
-152
-64.6
0
Sales and maturities of investments
36
1.3
7.8
4.8
0
Cash from investing
-168
91.7
187
-24.2
-74.2
-272
521
53.1
298
518
Debt issued
76.7
84.4
33.9
367
45.2
207
309
65.7
104
44.9
Debt repaid
-44.7
-35.8
-124
-291
-109
-236
-225
-58.4
-28.9
-143
Share buybacks
0
0
-4.9
-14.4
-160
-230
-113
-231
-320
Dividends paid
0
0
-22.4
-30.5
Cash from financing
-20.8
98.2
-86.4
319
379
-190
-154
-107
-183
-450
Net change in cash
99.2
77.4
211
191
-639
162
-142
25.3
50.5
Free cash flow
10.7
-130
-38.5
-113
-136
-190
-219
-97.8
-97.1
-28.5
Interest paid
8.7
8.7
3.3
15.6
5.5
7
9.6
13.6
6.3
6
Income taxes paid
4
118
0.2
48.6
108
129
100
4.6
0.9
-28.4
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $15.74 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
15.5%
Gross profit / revenue.
Operating margin
-28.4%
Operating income / revenue.
EBITDA margin
-25.8%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-9.7%
Pre-tax income / revenue.
Net margin
-38.2%
Net income / revenue.
FCF margin
-10.6%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-7.8%
Cash from operations / revenue.
Return on equity (ROE)
-16.3%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-12.4%
Net income / average total assets.
Return on invested capital (ROIC)
-9.6%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue
2.0%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
2.8%
Capital expenditures / revenue.
D&A / revenue
2.6%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-6.4%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-13.8%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-32.2%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-19.3%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-10.2%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y
-44.9%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-28.1%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-23.2%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-41.3%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-25.2%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-22.3%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
-12.3%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
-11.5%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
-8.0%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.24x
Current assets / current liabilities.
Quick ratio
0.46x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.46x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.07x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
5.6%
Total debt / total assets.
Liabilities / assets
27.5%
Total liabilities / total assets.
Net debt
-$500.0K
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$9.37
Revenue / diluted weighted shares.
FCF per share
-$1.00
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.73
Cash from operations / diluted weighted shares.
Book value per share
$22.08
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
1.67x
Market cap / revenue.
P/B
0.71x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
0.74x
Market cap / tangible book value, when positive.
EV/Sales
1.67x
Enterprise value / revenue.
FCF yield
-6.4%
Free cash flow / market cap.
Earnings yield
-22.9%
Net income / market cap (the inverse of P/E).
Dividend yield
4.2%
Dividends paid over the period / market cap.
Shareholder yield
41.3%
(Dividends paid + share buybacks) / market cap.
What was Cannae Holdings, Inc.'s revenue in fiscal 2025?
Cannae Holdings, Inc. reported revenue of $423.6M for fiscal 2025, 6.4% lower than the year before.
Was Cannae Holdings, Inc. profitable in fiscal 2025?
No. It reported a net loss of $513.2M.
How much free cash flow did Cannae Holdings, Inc. generate in fiscal 2025?
Cash from operations of $18.1M minus capital expenditures of $10.4M left free cash flow of -$28.5M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.